PMV Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PMVP research report →
Companywww.pmvpharma.com
PMV Pharmaceuticals, Inc. , a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function.
- CEO
- David H. Mack
- IPO
- 2020
- Employees
- 47
- HQ
- Princeton, NJ, US
Price Chart
Valuation
- Market Cap
- $69.86M
- P/E
- -0.89
- P/S
- 0.00
- P/B
- 0.79
- EV/EBITDA
- -0.38
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -68.98%
- ROIC
- -94.79%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-77,742,000 · -32.42%
- EPS
- $-1.48 · -30.03%
- Op Income
- $-86,206,000
- FCF YoY
- -41.72%
Performance & Tape
- 52W High
- $1.88
- 52W Low
- $0.85
- 50D MA
- $1.40
- 200D MA
- $1.34
- Beta
- 1.41
- Avg Volume
- 702.76K
Get TickerSpark's AI analysis on PMVP
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 5, 26 | Carulli Michael | other | 240,000 |
| Mar 5, 26 | Ticktin Robert | other | 319,270 |
| Mar 5, 26 | Jalota Deepika | other | 303,310 |
| Mar 5, 26 | Mack David Henry | other | 744,960 |
| Oct 27, 25 | Mack David Henry | other | 220,643 |
| Oct 27, 25 | Mack David Henry | other | 220,643 |
| Oct 23, 25 | ORBIMED ADVISORS LLC | sell | 1,000,000 |
| Sep 10, 25 | ORBIMED ADVISORS LLC | sell | 500,000 |
| Jul 1, 25 | Ticktin Robert | sell | 23,151 |
| Jul 1, 25 | Jalota Deepika | sell | 33,065 |
Our PMVP Coverage
We haven't published any research on PMVP yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PMVP Report →